Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | -0.26% | +1.85% | -32.57% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 42.29M | Sales 2025 * | 52.34M | Capitalization | 1.13B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -215M | EV / Sales 2024 * | 23.9 x |
Net cash position 2024 * | 120M | Net cash position 2025 * | 2M | EV / Sales 2025 * | 21.6 x |
P/E ratio 2024 * |
-6.73
x | P/E ratio 2025 * |
-6.25
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.02% |
Latest transcript on AbCellera Biologics Inc.
1 day | -0.26% | ||
1 week | +1.85% | ||
Current month | +1.85% | ||
1 month | -3.02% | ||
3 months | -20.94% | ||
6 months | -13.09% | ||
Current year | -32.57% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 12-11-07 | |
Founder | - | 12-11-07 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 20-10-31 |
Michael Hayden
BRD | Director/Board Member | 72 | 19-09-30 |
Andrew Lo
BRD | Director/Board Member | 63 | 21-12-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 0 M€ | 0.00% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +9.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 3.85 | -0.26% | 1,333,066 |
24-05-22 | 3.86 | +0.26% | 1,485,939 |
24-05-21 | 3.85 | +2.94% | 1,986,673 |
24-05-20 | 3.74 | +2.75% | 1,034,315 |
24-05-17 | 3.64 | -3.70% | 1,041,106 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.57% | 1.13B | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ABCL Stock